(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 1.9% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.8%.
Stevanato Group Spa's revenue in 2025 is $1,360,924,418.On average, 13 Wall Street analysts forecast STVN's revenue for 2025 to be $362,502,515,592, with the lowest STVN revenue forecast at $345,846,176,112, and the highest STVN revenue forecast at $374,616,217,032. On average, 13 Wall Street analysts forecast STVN's revenue for 2026 to be $394,300,981,872, with the lowest STVN revenue forecast at $348,571,758,936, and the highest STVN revenue forecast at $414,591,431,784.
In 2027, STVN is forecast to generate $438,515,992,128 in revenue, with the lowest revenue forecast at $412,471,534,032 and the highest revenue forecast at $460,320,654,720.